Future development of pentostatin (Nipent): opportunities for using a highly effective, safe agent for hematologic and autoimmune diseases. Proceedings of a conference. Puerto Rico, February 12-13, 1999.
D058892:Adenosine Deaminase Inhibitors; D000903:Antibiotics, Antineoplastic / Q000627:therapeutic use*; D001327:Autoimmune Diseases / Q000188:drug therapy*; D004791:Enzyme Inhibitors / Q000494:pharmacology; D019337:Hematologic Neoplasms / Q000188:drug therapy*; D006801:Humans; D007166:Immunosuppressive Agents / Q000627:therapeutic use*; D007938:Leukemia / Q000188:drug therapy; D008223:Lymphoma / Q000188:drug therapy; D015649:Pentostatin / Q000494:pharmacology / Q000627:therapeutic use*
D058892:Adenosine Deaminase Inhibitors; D000903:Antibiotics, Antineoplastic; D004791:Enzyme Inhibitors; D007166:Immunosuppressive Agents; D015649:Pentostatin